|
|
|
Volumn 25, Issue 2, 2011, Pages
|
|
Intraperitoneal drug delivery for ovarian cancer: Why, how, who, what, and when?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
BEVACIZUMAB;
BRCA1 PROTEIN;
CARBOPLATIN;
CISPLATIN;
CYCLOPHOSPHAMIDE;
CYTARABINE;
DOXORUBICIN;
FLOXURIDINE;
PACLITAXEL;
PLATINUM COMPLEX;
ABDOMINAL PAIN;
AREA UNDER THE CURVE;
BONE MARROW SUPPRESSION;
CANCER SURVIVAL;
DOSE RESPONSE;
DRUG BLOOD LEVEL;
DRUG CLEARANCE;
DRUG DOSE REDUCTION;
DRUG EFFICACY;
DRUG INDICATION;
DRUG SAFETY;
HUMAN;
MULTIPLE CYCLE TREATMENT;
NEUROPATHY;
NEUROTOXICITY;
NONHUMAN;
OUTCOME ASSESSMENT;
OVARY CANCER;
OVERALL SURVIVAL;
PERITONEUM;
PROGRESSION FREE SURVIVAL;
REVIEW;
SURVIVAL TIME;
TREATMENT PLANNING;
|
|
EID: 79952570779
PISSN: 08909091
EISSN: 08909091
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (11)
|
|
References (0)
|
